Important information.

Your IP address belongs to the address group of Russia. We inform you that starting from June 1, 2020, new clients from Russia are not registered. The company does not stop serving clients registered earlier. The change will affect the payments of the agents’ remuneration too. All registrations from June 1, 2020, for clients who are residents of the Russian Federation, will not be counted in the calculation of the agents’ remuneration. If you are a resident of Russia, take into account the fact of regulation of the activities of CFD dealers in the jurisdiction of the resident. In this regard, we inform that the company does not conduct advertising activities on the territory of Russia, has no registered offices under the Bulltraders brand,, or the name BT Technologies Ltd. BT Technologies Limited is an international company registered in the territory of the state of Saint Vincent and the Grenadines. By clicking on the "Continue" button, you accept the presence of the company in a foreign jurisdiction, confirm that you are a user who has reached the age of majority, and agree that the company has taken the necessary measures to provide this information to you.

Please accept our apologies. With best regards,

The previous Monday kicked off marked gains for the US stock market on hopes of a quick recovery from the pandemic-triggered recession.

Moderna (MRNA) announced on Monday that a coronavirus vaccine it is developing has shown 94.5% effectiveness in preventing COVID-19 in the later stages of trials. Thus, the effectiveness of the Moderna vaccine was higher than 90%, which showed the vaccine developed by Pfizer and BioNTech, which the companies reported last week. Promising announcements of effective COVID-19 vaccines have raised hopes for an economic recovery in 2021 when the vaccine becomes available. The market was also supported by better-than-expected macroeconomic data from China and Japan, the world's second and third largest economies, which indicated a "post-coronavirus" recovery.

The market declined the next day. The main reason was disappointing data on retail sales in the United States and the continuing rise in coronavirus cases across the country. A Commerce Department report showed US retail sales rose less-than-expected in October. According to the report, retail sales rose 0.3% in October, after rising 1.6% in September. Economists had forecast retail sales to rise 0.5% in October, following an earlier reported 1.9% rise.

The decline continued on Wednesday. Market participants were evaluating receiving an effective COVID-19 vaccine in the near future against the negative impact of the continued rise in coronavirus cases on the economy in the short term. A Commerce Department report showed that the number of new US homes in October rose more than expected. According to the report, the number of new homes added rose 4.9% to 1.530 million a year, after rising 6.3% to an upwardly revised 1.459 million in September. Economists had expected construction volume to jump to 1.460mn from 1.415mn originally announced in the previous month.

On Thursday, the dynamics changed, but the growth was not very impressive. A Labor Department report showed that initial jobless claims were 742,000 on a seasonally adjusted basis for the week ended November 14, up from 711,000 in the previous week. Economists forecast 707,000 applications in the last week. This marked the first increase in unemployment claims in five weeks, pointing to additional stress on the economy from a record rise in COVID-19 infections. Investors are concerned that while the world awaits the approval and distribution of any effective vaccine against COVID-19, governments are forced to impose tighter restrictions to slow the spread of the virus, causing further economic damage. In addition, the market sentiment was negatively affected by the lack of agreements on a package of additional measures to stimulate the economy.

The week ended with moderate decline. Yesterday on Thursday, US Treasury Secretary Stephen Mnuchin unexpectedly announced that $ 455 billion in unspent funds from the funds allocated by Congress to the Treasury in March under the US Pandemic Support Measures Act (CARES) and ultimately transferred to the Federal Reserve (Fed) for emergency lending to businesses, nonprofits and local governments, should be returned by the end of the year. The Fed, which has continued to urge lawmakers to increase fiscal support for the slowing economy while promising to keep interest rates near zero for at least three more years, has publicly deplored Mnuchin's demand.


Company news

15.01.2021 Changes in entrance to mobile trading platform Read more ...
18.12.2020 Broker's identification in a mobile platform. Read more ...
18.12.2020 Changes in the schedule of trading sessions in connection with the celebration of the Catholic Christmas. Read more ...
18.12.2020 Happy Xmas and Happy new year! Read more ...
01.06.2020 Stop of registration for residents of the Russian Federation Read more ...
Show all

Expert view

11.01.2021 First trading week Read more ...
11.01.2021 OPEC compromise Read more ...
20.12.2020 Fed's expected decision Read more ...
20.12.2020 Will the vaccine help oil market? Read more ...
14.12.2020 US stock market in "red zone" Read more ...
Show all

The payment services are provided by Cauri LTD, 20-22 Wenlock Road, London, N1 7GU, UK, registered number 09507138
(check, Win Pay (check


Our services include products that are traded on margin and carry a risk that you can lose more than your initial deposit. The products may not be suitable for everyone - please ensure you fully understand the risks involved. There is a high level of risk involved with trading leveraged products such as forex and CFDs. You should not risk more than you can afford to lose, it is possible that you may lose more than your initial investment. You should not trade unless you fully understand the true extent of your exposure to the risk of loss. When trading, you must always take into consideration your level of experience. It is the responsibility of the Client to ensure that the Client can accept the Services and/or enter into the Transactions in the country in which the Client is resident. If the risks involved seem unclear to you, please seek independent advice.